Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma

Journal of Clinical Investigation

Volumn 117, Issue 2, 2007, Pages 326-336

  Amaravadi, Ravi K ^a   Yu, Duonan ^b   Lum, Julian J ^a   Bui, Thi ^a   Christophorou, Maria A ^c   Evan, Gerard I ^c   Thomas Tikhonenko, Andrei ^b   Thompson, Craig B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHYLNITRONITROSOGUANIDINE; PROTEIN P53; SHORT HAIRPIN RNA; TAMOXIFEN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LYMPHOMA; MONOTHERAPY; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR CELL; TUMOR RECURRENCE; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CHLOROQUINE; GENES, MYC; GENES, P53; LYMPHOMA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; TAMOXIFEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846794896     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28833     Document Type: Article

References (54)

1. Kanzawa, T., et al. 2004. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11:448-457.
2. Paglin, S., et al. 2001. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61:439-444.
3. Bursch, W., et al. 1996. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis. 17:1595-1607.
4. Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S. 2005. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer. 5:726-734.
5. Yu, L., et al. 2004. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science. 304:1500-1502.
6. Qu, X., et al. 2003. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112:1809-1820. doi:10.1172/JCI200320039.
7. Kiffin, R., Christian, C., Knecht, E., and Cuervo, A.M. 2004. Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell. 15:4829-4840.
8. Benhar, M., Dalyot, I., Engelberg, D., and Levitzki, A. 2001. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 21:6913-6926.
9. Lum, J.J., et al. 2005. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 120:237-248.
10. Poole, B., and Ohkuma, S. 1981. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J. Cell Biol. 90:665-669.
11. Glaumann, H., and Ahlberg, J. 1987. Comparison of different autophagic vacuoles with regard to ultrastructure, enzymatic composition, and degradation capacity - formation of crinosomes. Exp. Mol. Pathol. 47:346-362.
12. Gonzalez-Polo, R.A., et al. 2005. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J. Cell Sci. 118:3091-3102.
13. Christophorou, M.A., et al. 2005. Temporal dissection of p53 function in vitro and in vivo. Nat. Genet. 37:718-726.
14. Littlewood, T.D., Hancock, D.C., Danielian, P.S., Parker, M.G., and Evan, G.I. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
15. Vater, C.A., Bartle, L.M., Dionne, C.A., Littlewood, T.D., and Goldmacher, V.S. 1996. Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts. Oncogene. 13:739-748.
16. Yu, D., and Thomas-Tikhonenko, A. 2002. A nontransgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Oncogene. 21:1922-1927.
17. Yu, D., Dews, M., Park, A., Tobias, J.W., and Thomas-Tikhonenko, A. 2005. Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies. Cancer Res. 65:5454-5461.
18. Wiselogle, F.Y. 1946. A survey of antimalarial drugs, 1941-1945. J.W. Edwards. Ann Arbor, Michigan, USA. 134 pp.
19. Michihara, A., et al. 2005. Disruptive effect of chloroquine on lysosomes in cultured rat hepatocytes. Biol. Pharm. Bull. 28:947-951.
20. Fedorko, M.E., Hirsch, J.G., and Cohn, Z.A. 1968. Autophagic vacuoles produced in vitro. II. Studies on the mechanism of formation of autophagic vacuoles produced by chloroquine. J. Cell Biol. 38:392-402.
21. Boya, P., et al. 2005. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25:1025-1040.
22. Tanida, I., Ueno, T., and Kominami, E. 2004. LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol. 36:2503-2518.
23. Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., and Ohsumi, Y. 2004. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell. 15:1101-1111.
24. Mizushima, N., et al. 2001. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 152:657-668.
25. Elmore, S.P., Qian, T., Grissom, S.F., and Lemasters, J.J. 2001. The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J. 15:2286-2287.
26. Lum, J.J., DeBerardinis, R.J., and Thompson, C.B. 2005. Autophagy in metazoans: cell survival in the land of plenty. Nat. Rev. Mol. Cell Biol. 6:439-448.
27. Coiffier, B. 2005. State-of-the-art therapeutics: diffuse large B-cell lymphoma. J. Clin. Oncol. 23:6387-6393.
28. Witzig, T.E. 2005. Current treatment approaches for mantle-cell lymphoma. J. Clin. Oncol. 23:6409-6414.
29. Hiddemann, W., et al. 2005. Treatment strategies in follicular lymphomas: current status and future perspectives. J. Clin. Oncol. 23:6394-6399.
30. Kim, W.J., Beardsley, D.I., Adamson, A.W., and Brown, K.D. 2005. The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways. Toxicol. Appl. Pharmacol. 202:84-98.
31. Prasad, R.N., Mahajan, R.C., and Ganguly, N.K. 1987. Effect of chloroquine on cellular immune responses of normal and P. knowlesi-infected rhesus monkeys. Immunol. Cell Biol. 65:211-216.
32. Yin, F., Guo, M., and Yao, S. 2003. Kinetics of DNA binding with chloroquine phosphate using capacitive sensing method. Biosens. Bioelectron. 19:297-304.
33. Aita, V.M., et al. 1999. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 59:59-65.
34. Liang, X.H., et al. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 402:672-676.
35. Gu, Y., Wang, C., and Cohen, A. 2004. Effect of IGF-1 on the balance between autophagy of dysfunctional mitochondria and apoptosis. FEBS Lett. 577:357-360.
36. Iwata, J.I., et al. 2005. Excess peroxisomes are degraded by autophagic machinery in mammals. J. Biol. Chem. 281:4035-4041.
37. Kissova, I., Deffieu, M., Manon, S., and Camougrand, N. 2004. Uth1p is involved in the autophagic degradation of mitochondria. J. Biol. Chem. 279:39068-39074.
38. Bandara, P.D., Flattery-O'Brien, J.A., Grant, C.M., and Dawes, I.W. 1998. Involvement of the Saccharomyces cerevisiae UTH1 gene in the oxidative-stress response. Curr. Genet. 34:259-268.
39. Gorka, M., et al. 2005. Autophagy is the dominant type of programmed cell death in breast cancer MCF-7 cells exposed to AGS 115 and EFDAC, new sesquiterpene analogs of paclitaxel. Anticancer Drugs. 16:777-788.
40. Gozuacik, D., and Kimchi, A. 2004. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 23:2891-2906.
41. Boxer, L.M., and Dang, C.V. 2001. Translocations involving c-myc and c-myc function. Oncogene. 20:5595-5610.
42. Little, C.D., Nau, M.M., Carney, D.N., Gazdar, A.F., and Minna, J.D. 1983. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature. 306:194-196.
43. Mariani-Costantini, R., et al. 1988. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res. 48:199-205.
44. Augenlicht, L.H., et al. 1997. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res. 57:1769-1775.
45. Hemann, M.T., et al. 2005. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature. 436:807-811.
46. Erisman, M.D., et al. 1985. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol. Cell. Biol. 5:1969-1976.
47. Escot, C., et al. 1986. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc. Natl. Acad. Sci. U. S. A. 83:4834-4838.
48. Dang, C.V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1-11.
49. Degenhardt, K., et al. 2006. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 10:51-64.
50. O'Neill, P.M., Bray, P.G., Hawley, S.R., Ward, S.A., and Park, B.K. 1998. 4-Aminoquinolines-past, present, and future: a chemical perspective. Pharmacol. Ther. 77:29-58.
51. Kremer, J.M. 2001. Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Ann. Intern. Med. 134:695-706.
52. Walenta, S., Schroeder, T., and Mueller-Klieser, W. 2004. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr. Med. Chem. 11:2195-2204.
53. Carmichael, S.J., Charles, B., and Tett, S.E. 2003. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther. Drug Monit. 25:671-681.
54. Munster, T., et al. 2002. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis Rheum. 46:1460-1469.